Impact of diabetes mellitus on outcomes in patients with colon cancer

Journal of Clinical Oncology

Volumn 21, Issue 3, 2003, Pages 433-440

  Meyerhardt, Jeffrey A ^a   Catalano, Paul J ^a   Haller, Daniel G ^a   Mayer, Robert J ^a   Macdonald, John S ^a   Benson III, Al B ^a   Fuchs, Charles S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CLINICAL TRIAL; COHORT ANALYSIS; COLON CANCER; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE FREE SURVIVAL; DRUG TOLERABILITY; FOLLOW UP; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; OVERALL SURVIVAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL TIME; TREATMENT OUTCOME; AGED; COLON TUMOR; FEMALE; MALE; MIDDLE AGED; RISK FACTOR; TUMOR RECURRENCE;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; COLONIC NEOPLASMS; DIABETES COMPLICATIONS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RISK FACTORS; TREATMENT OUTCOME;

EID: 0037313036     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2003.07.125     Document Type: Article

References (38)

1. Williams JC, Walsh DA, Jackson JF: Colon carcinoma and diabetes mellitus. Cancer 54:3070-3071, 1984
2. O'Mara BA, Byers T, Schoenfeld E: Diabetes mellitus and cancer risk: A multisite case-control study. J Chronic Dis 38:435-441, 1985
3. Adami HO, McLaughlin J, Ekbom A, et al: Cancer risk in patients with diabetes mellitus. Cancer Causes Control 2:307-314, 1991
4. La Vecchia C, D'Avanzo B, Negri E, et al: History of selected diseases and the risk of colorectal cancer. Eur J Cancer 27:582-586, 1991
5. Ragozzino M, Melton LJ 3rd, Chu CP, et al: Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. J Chronic Dis 35:13-19, 1982
6. Kono S, Honjo S, Todoroki I, et al: Glucose intolerance and adenomas of the sigmoid colon in Japanese men (Japan). Cancer Causes Control 9:441-446, 1998
7. Will JC, Galuska DA, Vinicor F, et al: Colorectal cancer: Another complication of diabetes mellitus? Am J Epidemiol 147:816-825, 1998
8. Hu FB, Manson JE, Liu S, et al: Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst 91:542-547, 1999
9. Nilsen TI, Vatten LJ: Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: Exploring the hyperinsulinaemia hypothesis. Br J Cancer 84:417-422, 2001
10. Le Marchand L, Wilkens LR, Kolonel LN, et al: Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer. Cancer Res 57:4787-4794, 1997
11. Kaaks R, Toniolo P, Akhmedkhanov A, et al: Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 92:1592-1600, 2000
12. Schoen RE, Tangen CM, Kuller LH, et al: Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst 91:1147-1154, 1999
13. Sperti C, Pasquali C, Piccoli A, et al: Survival after resection for ductal adenocarcinoma of the pancreas. Br J Surg 83:625-631, 1996
14. Toyoda H, Kumada T, Nakano S, et al: Impact of diabetes mellitus on the prognosis of patients with hepatocellular carcinoma. Cancer 91:957-963, 2001
15. Yancik R, Wesley MN, Ries LA, et al: Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA 285:885-892, 2001
16. Payne JE, Meyer HJ: The influence of other diseases upon the outcome of colorectal cancer patients. Aust N Z J Surg 65:398-402, 1995
17. Yancik R, Wesley MN, Ries LA, et al: Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: A population-based study. Cancer 82:2123-2134, 1998
18. Haller DG, Catalano PJ, Macdonald JS, et al: Fluorouracil (FU), leucovorin (LV) and levamisole (LEV) adjuvant therapy for colon cancer: Four-year results of INT-0089. Proc Am Soc Clin Oncol 1997 (abstr 940)
19. Haller DG, Catalano PJ, Macdonald JS, et al: Fluorouracil (FU), leucovorin (LV) and levamisole (LEV) adjuvant therapy for colon cancer: Five-year final report of INT-0089. Proc Am Soc Clin Oncol 1998 (abstr 982)
20. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
21. Cox D: Regression models and life tables. J R Stat Soc B 34:187-220, 1972
22. McCollum AD, Catalano PJ, Haller DG, et al: Outcomes and toxicity in African-American and Caucasian patients in a randomized adjuvant chemotherapy trial for colon cancer. J Natl Cancer Inst 94:1160-1167, 2002
23. Mosteller RD: Simplified calculation of body-surface area. N Engl J Med 317:1098, 1987
24. Giovannucci E: Insulin and colon cancer. Cancer Causes Control 6:164-179, 1995
25. Tran TT, Medline A, Bruce WR: Insulin promotion of colon tumors in rats. Cancer Epidemiol Biomarkers Prev 5:1013-1015, 1996
26. Ma J, Pollak MN, Giovannucci E, et al: Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst 91:620-625, 1999
27. Ma J, Pollak M, Giovannucci E, et al: A prospective study of plasma levels of insulin-like growth factor I (IGF-I) and IGF-binding protein-3, and colorectal cancer risk among men. Growth Horm IGF Res 10:S28-S29, 2000 (suppl A)
28. Giovannucci E, Pollak MN, Platz EA, et al: A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol Biomarkers Prev 9:345-349, 2000
29. Manousos O, Souglakos J, Bosetti C, et al: IGF-I and IGF-II in relation to colorectal cancer. Int J Cancer 83:15-17, 1999
30. Rechler MM: Growth inhibition by insulin-like growth factor (IGF) binding protein-3-what's IGF got to do with it? Endocrinology 138:2645-2647, 1997
31. Kaaks R, Lukanova A: Energy balance and cancer: The role of insulin and insulin-like growth factor-I. Proc Nutr Soc 60:91-106, 2001
32. Goodwin PJ, Ennis M, Pritchard KJ, et al: Fasting insulin and outcome in early-stage breast cancers: Results of a prospective cohort study. J Clin Oncol 20:42-51, 2002
33. La Vecchia C, Negri E, Decarli A, et al: Diabetes mellitus and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 6:1007-1010, 1997
34. Extermann M: Measuring comorbidity in older cancer patients. Eur J Cancer 36:453-471, 2000
35. Extermann M: Measurement and impact of comorbidity in older cancer patients. Crit Rev Oncol Hematol 35:181-200, 2000
36. Extermann M, Overcash J, Lyman GH, et al: Comorbidity and functional status are independent in older cancer patients. J Clin Oncol 16:1582-1587, 1998
37. Jaeger AA, Hlatky MA, Paul SM, et al: Functional capacity after cardiac surgery in elderly patients. J Am Coll Cardiol 24:104-108, 1994
38. Greenfield S, Apolone G, McNeil BJ, et al: The importance of co-existent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement. Comorbidity and outcomes after hip replacement. Med Care 31:141-154, 1993